全文获取类型
收费全文 | 17692篇 |
免费 | 1964篇 |
国内免费 | 119篇 |
专业分类
耳鼻咽喉 | 258篇 |
儿科学 | 248篇 |
妇产科学 | 358篇 |
基础医学 | 1459篇 |
口腔科学 | 6974篇 |
临床医学 | 1017篇 |
内科学 | 2918篇 |
皮肤病学 | 198篇 |
神经病学 | 996篇 |
特种医学 | 476篇 |
外科学 | 2355篇 |
综合类 | 35篇 |
预防医学 | 550篇 |
眼科学 | 125篇 |
药学 | 677篇 |
中国医学 | 31篇 |
肿瘤学 | 1100篇 |
出版年
2024年 | 34篇 |
2023年 | 420篇 |
2022年 | 235篇 |
2021年 | 404篇 |
2020年 | 323篇 |
2019年 | 342篇 |
2018年 | 613篇 |
2017年 | 589篇 |
2016年 | 683篇 |
2015年 | 818篇 |
2014年 | 1033篇 |
2013年 | 1084篇 |
2012年 | 1175篇 |
2011年 | 1188篇 |
2010年 | 854篇 |
2009年 | 1031篇 |
2008年 | 985篇 |
2007年 | 970篇 |
2006年 | 824篇 |
2005年 | 786篇 |
2004年 | 768篇 |
2003年 | 695篇 |
2002年 | 552篇 |
2001年 | 243篇 |
2000年 | 206篇 |
1999年 | 238篇 |
1998年 | 304篇 |
1997年 | 272篇 |
1996年 | 252篇 |
1995年 | 226篇 |
1994年 | 226篇 |
1993年 | 178篇 |
1992年 | 168篇 |
1991年 | 124篇 |
1990年 | 121篇 |
1989年 | 80篇 |
1988年 | 107篇 |
1987年 | 93篇 |
1986年 | 56篇 |
1985年 | 72篇 |
1984年 | 76篇 |
1983年 | 67篇 |
1982年 | 59篇 |
1981年 | 40篇 |
1979年 | 15篇 |
1978年 | 16篇 |
1977年 | 17篇 |
1976年 | 16篇 |
1975年 | 21篇 |
1974年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Ferreli Fabio Mercante Giuseppe De Virgilio Armando Di Maio Pasquale Iocca Oreste Pellini Raul Spriano Giuseppe 《European archives of oto-rhino-laryngology》2020,277(6):1837-1841
European Archives of Oto-Rhino-Laryngology - To analyze the surgical outcomes in terms of postoperative wound complications in a small case series of six patients treated with lateral cervical... 相似文献
993.
Victoria Lavin Fabio Callipo Carmine A. Donofrio Rhianedd Ellwood-Thompson Robert Metcalf Ibrahim Djoukhadar Claire E. Higham Tara Kearney Rovel Colaco Kanna Gnanalingham Federico Roncaroli 《Neuropathology》2020,40(3):261-267
Primary salivary gland-like tumors of the sella are rare and often challenging to diagnose. They reportedly derive from serous and mucinous glands that remain trapped in the infundibulum during embryogenesis. We report a 68-year-old man who presented with partial left third cranial nerve palsy, visual loss in the left eye without visual field defects, headache, weight loss and reduced muscle bulk. Neuroimaging studies demonstrated a solid and cystic, avidly enhancing lesion expanding the pituitary fossa and extending to the left cavernous sinus. The patient underwent craniotomy and the tissue removed showed features of epithelial-myoepithelial carcinoma similar to the salivary gland, skin and breast counterpart. No primary tumor was found outside the sella. The lesion behaved aggressively despite radio-chemotherapy and the patient died 22 months from the onset. The tumor showed a novel TP53 in-frame deletion (Gly154del) while no variants were found in H-RAS hotspot regions (codons 12, 13 and 61). Our report expands the spectrum of salivary gland-like tumors primarily occurring in the sella and emphasizes the need for specialist review of rare, non-neuroendocrine tumors of the pituitary and sella regions. 相似文献
994.
Hirjak Dusan Kubera Katharina Maria Sambataro Fabio Wolf Robert Christian 《European archives of psychiatry and clinical neuroscience》2020,270(3):399-400
European Archives of Psychiatry and Clinical Neuroscience - 相似文献
995.
Matteo Lambertini Francesca Poggio Marco Bruzzone Benedetta Conte Claudia Bighin Evandro de Azambuja Mario Giuliano Michele De Laurentiis Francesco Cognetti Alessandra Fabi Giancarlo Bisagni Antonio Durando Anna Turletti Ylenia Urracci Ornella Garrone Fabio Puglisi Filippo Montemurro Marcello Ceppi Lucia Del Mastro the GIM investigators 《International journal of cancer. Journal international du cancer》2020,147(1):160-169
Dose-dense adjuvant chemotherapy is standard of care in high-risk early breast cancer patients. However, its role in HER2-positive patients is still uncertain. In this exploratory analysis of the GIM2 trial, we investigated the efficacy of dose-dense chemotherapy in HER2-positive breast cancer patients with or without exposure to trastuzumab. In the GIM2 trial, node-positive early breast cancer patients were randomized to receive four cycles of (fluorouracil)epirubicin/cyclophosphamide followed by four cycles of paclitaxel administered every 2 (dose-dense) or 3 (standard-interval) weeks. After approval of adjuvant trastuzumab, protocol was amended in April 2006 to allow use of trastuzumab for 1 year after chemotherapy completion in HER2-positive patients. The efficacy of dose-dense chemotherapy in terms of disease-free survival (DFS) and overall survival (OS) was assessed according to HER2 status and trastuzumab use. Out of 2,003 breast cancer patients, HER2 status was negative/unknown in 1,551 patients; among the 452 patients with HER2-positive breast cancer, chemotherapy alone or followed by trastuzumab was given to 320 and 132 patients, respectively. Median follow-up was 8.1 years. No significant interaction between HER2 status, trastuzumab use and chemotherapy treatment was observed for both DFS (p = 0.698) and OS (p = 0.708). Nevertheless, there was no apparent benefit in the HER2-positive group treated with trastuzumab (DFS: HR, 0.99; 95% CI 0.52–1.89; OS: HR, 0.95; 95% CI 0.37–2.41). Although dose-dense chemotherapy was associated with a significant survival improvement in high-risk breast cancer patients, its benefit appeared to be smaller (if any) in patients with HER2-positive disease who received adjuvant trastuzumab. 相似文献
996.
Josué Hernando MD DDS PhD Pablo Aguirre MD Antonio Aguilar-Salvatierra DDS PhD Ignacio Osoitz Leizaola-Cardesa DDS PhD Ainhoa Bidaguren MD Gerardo Gómez-Moreno DDS PhD 《Journal of surgical oncology》2020,121(2):244-248
The aim was to evaluate sentinel node detection capacity by means of a magnetic probe in 11 patients with oral squamous cell carcinoma at stages T1-T2 received submucosal injections of a superparamagnetic iron oxide contrast agent (SPIO). A magnetic probe was used for sentinel node biopsy. The use of SPIO and magnetic probes in the early stages of oral cancer may offer an alternative to conventional radioisotope techniques and/or elective neck dissection. 相似文献
997.
998.
Robert J. Motzer MD Bernard Escudier MD Saby George MD Hans J. Hammers MD PhD Sandhya Srinivas MD Scott S. Tykodi MD PhD Jeffrey A. Sosman MD Elizabeth R. Plimack MD Giuseppe Procopio MD David F. McDermott MD Daniel Castellano MD Toni K. Choueiri MD Frede Donskov MD PhD Howard Gurney MD Stéphane Oudard MD Martin Richardet MD PhD Katriina Peltola MD PhD Ajjai S. Alva MD Michael Carducci MD John Wagstaff MD Christine Chevreau MD Satoshi Fukasawa MD Yoshihiko Tomita MD PhD Thomas C. Gauler MD Christian K. Kollmannsberger MD Fabio A. Schutz PhD James Larkin MD PhD David Cella PhD M. Brent McHenry PhD Shruti Shally Saggi BEng Nizar M. Tannir MD 《Cancer》2020,126(18):4156-4167
999.
1000.
Rossi Luigi Verrico Monica Tomao Silverio Ricci Fabio Fontana Antonella Spinelli Gian Paolo Colonna Maria Vici Patrizia Tomao Federica 《Cancer chemotherapy and pharmacology》2020,85(1):105-111
Cancer Chemotherapy and Pharmacology - Many studies have indicated that the response to therapy and the prognostic impact of a pathologic complete response after neoadjuvant treatment differ among... 相似文献